Yair Reisner - Publications

Affiliations: 
IMM Immunology Weizmann Institute of Science, Rehovot, Israel 
Area:
Immunology, Cell Biology

73/230 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Hillel-Karniel C, Rosen C, Milman-Krentsis I, Orgad R, Bachar-Lustig E, Shezen E, Reisner Y. Multi-lineage Lung Regeneration by Stem Cell Transplantation across Major Genetic Barriers. Cell Reports. 30: 807-819.e4. PMID 31968255 DOI: 10.1016/j.celrep.2019.12.058  0.64
2018 Milman Krentsis I, Rosen C, Shezen E, Aronovich A, Nathanson B, Bachar-Lustig E, Berkman N, Assayag M, Shakhar G, Feferman T, Orgad R, Reisner Y. Lung Injury Repair by Transplantation of Adult Lung Cells Following Preconditioning of Recipient Mice. Stem Cells Translational Medicine. 7: 68-77. PMID 29266820 DOI: 10.1002/sctm.17-0149  0.64
2016 Aharoni R, Rosen C, Shezen E, Bar-Lev DD, Golani O, Reisner Y, Sela M, Arnon R. Assessing remyelination - metabolic labeling of myelin in an animal model of multiple sclerosis. Journal of Neuroimmunology. PMID 27836179 DOI: 10.1016/j.jneuroim.2016.10.015  0.64
2015 Zlotnikov-Klionsky Y, Nathansohn-Levi B, Shezen E, Rosen C, Kagan S, Bar-On L, Jung S, Shifrut E, Reich-Zeliger S, Friedman N, Aharoni R, Arnon R, Yifa O, Aronovich A, Reisner Y. Perforin-Positive Dendritic Cells Exhibit an Immuno-regulatory Role in Metabolic Syndrome and Autoimmunity. Immunity. PMID 26384546 DOI: 10.1016/j.immuni.2015.08.015  0.64
2015 Rosen C, Shezen E, Aronovich A, Klionsky YZ, Yaakov Y, Assayag M, Biton IE, Tal O, Shakhar G, Ben-Hur H, Shneider D, Vaknin Z, Sadan O, Evron S, Freud E, ... ... Reisner Y, et al. Preconditioning allows engraftment of mouse and human embryonic lung cells, enabling lung repair in mice. Nature Medicine. 21: 869-79. PMID 26168294 DOI: 10.1038/nm.3889  0.64
2015 Stein ES, Itsekson-Hayosh Z, Aronovich A, Reisner Y, Bushi D, Pick CG, Tanne D, Chapman J, Vlachos A, Maggio N. Thrombin induces ischemic LTP (iLTP): implications for synaptic plasticity in the acute phase of ischemic stroke. Scientific Reports. 5: 7912. PMID 25604482 DOI: 10.1038/srep07912  0.64
2015 Martelli MF, Ianni MD, Ruggeri L, Falzetti F, Carotti A, Reisner Y, Velardi A. Next generation HLA-haploidentical HSCT Bone Marrow Transplantation. 50: S63-S66. DOI: 10.1038/bmt.2015.98  0.64
2015 Reisner Y, Aversa F, Martelli MF. Haploidentical hematopoietic stem cell transplantation: State of art Bone Marrow Transplantation. 50: S1-S5. DOI: 10.1038/bmt.2015.86  0.64
2014 Martelli MF, Di Ianni M, Ruggeri L, Falzetti F, Carotti A, Terenzi A, Pierini A, Massei MS, Amico L, Urbani E, Del Papa B, Zei T, Iacucci Ostini R, Cecchini D, Tognellini R, ... Reisner Y, et al. HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse. Blood. 124: 638-44. PMID 24923299 DOI: 10.1182/blood-2014-03-564401  0.64
2014 Martelli MF, Di Ianni M, Ruggeri L, Pierini A, Falzetti F, Carotti A, Terenzi A, Reisner Y, Aversa F, Falini B, Velardi A. "Designed" grafts for HLA-haploidentical stem cell transplantation. Blood. 123: 967-73. PMID 24363403 DOI: 10.1182/blood-2013-10-531764  0.64
2013 Aronovich A, Nur Y, Shezen E, Rosen C, Zlotnikov Klionsky Y, Milman I, Yarimi L, Hagin D, Rechavi G, Martinowitz U, Nagasawa T, Frenette PS, Tchorsh-Yutsis D, Reisner Y. A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure. Blood. 122: 2562-71. PMID 23982175 DOI: 10.1182/blood-2012-08-447458  0.64
2013 Eventov-Friedman S, Reisner Y. Fetal pancreas as a source for islet transplantation: sweet promise and current challenges. Diabetes. 62: 1382-3. PMID 23613558 DOI: 10.2337/db13-0018  1
2013 Lask A, Ophir E, Or-Geva N, Cohen-Fredarow A, Afik R, Eidelstein Y, Reich-Zeliger S, Nathansohn B, Edinger M, Negrin RS, Hagin D, Reisner Y. A new approach for eradication of residual lymphoma cells by host nonreactive anti-third-party central memory CD8 T cells. Blood. 121: 3033-40. PMID 23446736 DOI: 10.1182/blood-2012-06-432443  0.64
2013 Ophir E, Or-Geva N, Gurevich I, Tal O, Eidelstein Y, Shezen E, Margalit R, Lask A, Shakhar G, Hagin D, Bachar-Lustig E, Reich-Zeliger S, Beilhack A, Negrin R, Reisner Y. Murine anti-third-party central-memory CD8(+) T cells promote hematopoietic chimerism under mild conditioning: lymph-node sequestration and deletion of anti-donor T cells. Blood. 121: 1220-8. PMID 23223359 DOI: 10.1182/blood-2012-07-441493  0.64
2012 Mirelman D, Bayer EA, Reisner Y. Nathan Sharon. 1925-2011 Advances in Carbohydrate Chemistry and Biochemistry. 67: 2-18. PMID 22973609 DOI: 10.1016/B978-0-12-396527-1.00001-2  0.64
2012 Zuckerman T, Katz T, Haddad N, Fineman R, Dann EJ, Avivi I, Ofran Y, Gavish I, Faibish T, Sahar D, Hertz E, Sabo E, Reisner Y, Rowe JM. Allogeneic stem cell transplantation for patients with chronic myeloid leukemia: risk stratified approach with a long-term follow-up. American Journal of Hematology. 87: 875-9. PMID 22847303 DOI: 10.1002/ajh.23263  0.64
2012 Zangi L, Klionsky YZ, Yarimi L, Bachar-Lustig E, Eidelstein Y, Shezen E, Hagin D, Ito Y, Takai T, Reich-Zeliger S, Lask A, Milstein O, Jung S, Shinder V, Reisner Y. Deletion of cognate CD8 T cells by immature dendritic cells: a novel role for perforin, granzyme A, TREM-1, and TLR7. Blood. 120: 1647-57. PMID 22776817 DOI: 10.1182/blood-2012-02-410803  0.64
2011 Reisner Y, Martelli MF. The importance of bone marrow transplantation for patients who do not have a matched sibling donor. Best Practice & Research. Clinical Haematology. 24: 323-4. PMID 21925084 DOI: 10.1016/j.beha.2011.06.002  0.64
2011 Tchorsh-Yutsis D, Zlotnikov Klionsky Y, Bachar-Lustig E, Aronovich A, Feine I, Shezen E, Rosen C, Bitcover R, Eventov-Friedman S, Katchman H, Zangi L, Tal O, Cohen S, Reisner Y. Embryonic pig pancreatic tissue for the treatment of diabetes: potential role of immune suppression with "off-the-shelf" third-party regulatory T cells. Transplantation. 91: 398-405. PMID 21192322 DOI: 10.1097/TP.0b013e318204be15  0.64
2011 Milstein O, Hagin D, Lask A, Reich-Zeliger S, Shezen E, Ophir E, Eidelstein Y, Afik R, Antebi YE, Dustin ML, Reisner Y. CTLs respond with activation and granule secretion when serving as targets for T-cell recognition. Blood. 117: 1042-52. PMID 21045195 DOI: 10.1182/blood-2010-05-283770  0.52
2010 Cohen S, Tchorsh-Yutsis D, Aronovich A, Tal O, Eventov-Friedman S, Katchman H, Klionsky Y, Shezen E, Reisner Y. Growth enhancement by embryonic fibroblasts upon cotransplantation of noncommitted pig embryonic tissues with fully committed organs. Transplantation. 89: 1198-207. PMID 20195218 DOI: 10.1097/TP.0b013e3181d720fd  0.64
2009 Aronovich A, Tchorsh D, Shezen E, Rosen C, Klionsky Y, Cohen S, Tal O, Martinowitz U, Katchman H, Eventov-Friedman S, Amariglio N, Jacob-Hirsch J, Rechavi G, Reisner Y. Enhancement of pig embryonic implants in factor VIII KO mice: a novel role for the coagulation cascade in organ size control. Plos One. 4: e8362. PMID 20027227 DOI: 10.1371/journal.pone.0008362  0.64
2009 Zangi L, Margalit R, Reich-Zeliger S, Bachar-Lustig E, Beilhack A, Negrin R, Reisner Y. Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells. Stem Cells (Dayton, Ohio). 27: 2865-74. PMID 19750539 DOI: 10.1002/stem.217  0.64
2009 Hecht G, Eventov-Friedman S, Rosen C, Shezen E, Tchorsh D, Aronovich A, Freud E, Golan H, El-Hasid R, Katchman H, Hering BJ, Zung A, Kra-Oz Z, Shaked-Mishan P, Yusim A, ... ... Reisner Y, et al. Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model. Proceedings of the National Academy of Sciences of the United States of America. 106: 8659-64. PMID 19433788 DOI: 10.1073/pnas.0812253106  0.64
2009 Tchorsh-Yutsis D, Hecht G, Aronovich A, Shezen E, Klionsky Y, Rosen C, Bitcover R, Eventov-Friedman S, Katchman H, Cohen S, Tal O, Milstein O, Yagita H, Blazar BR, Reisner Y. Pig embryonic pancreatic tissue as a source for transplantation in diabetes: transient treatment with anti-LFA1, anti-CD48, and FTY720 enables long-term graft maintenance in mice with only mild ongoing immunosuppression. Diabetes. 58: 1585-94. PMID 19401429 DOI: 10.2337/db09-0112  0.64
2008 Wasserstrom A, Frumkin D, Adar R, Itzkovitz S, Stern T, Kaplan S, Shefer G, Shur I, Zangi L, Reizel Y, Harmelin A, Dor Y, Dekel N, Reisner Y, Benayahu D, et al. Estimating cell depth from somatic mutations. Plos Computational Biology. 4: e1000058. PMID 18404205 DOI: 10.1371/journal.pcbi.1000058  0.64
2008 Wasserstrom A, Adar R, Shefer G, Frumkin D, Itzkovitz S, Stern T, Shur I, Zangi L, Kaplan S, Harmelin A, Reisner Y, Benayahu D, Tzahor E, Segal E, Shapiro E. Reconstruction of cell lineage trees in mice. Plos One. 3: e1939. PMID 18398465 DOI: 10.1371/journal.pone.0001939  0.64
2008 Katchman H, Tal O, Eventov-Friedman S, Shezen E, Aronovich A, Tchorsh D, Cohen S, Shtabsky A, Hecht G, Dekel B, Freud E, Reisner Y. Embryonic porcine liver as a source for transplantation: advantage of intact liver implants over isolated hepatoblasts in overcoming homeostatic inhibition by the quiescent host liver. Stem Cells (Dayton, Ohio). 26: 1347-55. PMID 18339772 DOI: 10.1634/stemcells.2007-0631  0.64
2008 Reisner Y, Martelli MF. From 'megadose' haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantation. Blood Cells, Molecules & Diseases. 40: 1-7. PMID 17981059 DOI: 10.1016/j.bcmd.2007.06.030  0.64
2006 Aronovich A, Tchorsh D, Katchman H, Eventov-Friedman S, Shezen E, Martinowitz U, Blazar BR, Cohen S, Tal O, Reisner Y. Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantation. Proceedings of the National Academy of Sciences of the United States of America. 103: 19075-80. PMID 17148607 DOI: 10.1073/pnas.0607012103  0.64
2006 Dekel B, Zangi L, Shezen E, Reich-Zeliger S, Eventov-Friedman S, Katchman H, Jacob-Hirsch J, Amariglio N, Rechavi G, Margalit R, Reisner Y. Isolation and characterization of nontubular sca-1+lin- multipotent stem/progenitor cells from adult mouse kidney. Journal of the American Society of Nephrology : Jasn. 17: 3300-14. PMID 17093069 DOI: 10.1681/ASN.2005020195  1
2006 Dekel B, Metsuyanim S, Schmidt-Ott KM, Fridman E, Jacob-Hirsch J, Simon A, Pinthus J, Mor Y, Barasch J, Amariglio N, Reisner Y, Kaminski N, Rechavi G. Multiple imprinted and stemness genes provide a link between normal and tumor progenitor cells of the developing human kidney. Cancer Research. 66: 6040-9. PMID 16778176 DOI: 10.1158/0008-5472.CAN-05-4528  0.44
2006 Eventov-Friedman S, Tchorsh D, Katchman H, Shezen E, Aronovich A, Hecht G, Dekel B, Rechavi G, Blazar BR, Feine I, Tal O, Freud E, Reisner Y. Embryonic pig pancreatic tissue transplantation for the treatment of diabetes. Plos Medicine. 3: e215. PMID 16768546 DOI: 10.1371/journal.pmed.0030215  0.64
2006 Steiner D, Brunicki N, Bachar-Lustig E, Taylor PA, Blazar BR, Reisner Y. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin. Experimental Hematology. 34: 802-8. PMID 16728286 DOI: 10.1016/j.exphem.2006.02.017  0.52
2006 Steiner D, Brunicki N, Blazar BR, Bachar-Lustig E, Reisner Y. Tolerance induction by third-party "off-the-shelf" CD4+CD25+ Treg cells. Experimental Hematology. 34: 66-71. PMID 16413392 DOI: 10.1016/j.exphem.2005.10.011  0.52
2006 Dekel B, Shezen E, Even-Tov-Friedman S, Katchman H, Margalit R, Nagler A, Reisner Y. Transplantation of human hematopoietic stem cells into ischemic and growing kidneys suggests a role in vasculogenesis but not tubulogenesis. Stem Cells (Dayton, Ohio). 24: 1185-93. PMID 16410390 DOI: 10.1634/stemcells.2005-0265  0.64
2006 Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E, Mandelboim O, Reisner Y, Benvenisty N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells (Dayton, Ohio). 24: 221-9. PMID 16109762 DOI: 10.1634/stemcells.2005-0188  0.64
2005 Eventov-Friedman S, Katchman H, Shezen E, Aronovich A, Tchorsh D, Dekel B, Freud E, Reisner Y. Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows. Proceedings of the National Academy of Sciences of the United States of America. 102: 2928-33. PMID 15710886 DOI: 10.1073/pnas.0500177102  1
2005 Gur H, Krauthgamer R, Bachar-Lustig E, Katchman H, Arbel-Goren R, Berrebi A, Klein T, Nagler A, Tabilio A, Martelli MF, Reisner Y. Immune regulatory activity of CD34+ progenitor cells: evidence for a deletion-based mechanism mediated by TNF-alpha. Blood. 105: 2585-93. PMID 15471953 DOI: 10.1182/blood-2002-11-3463  0.64
2005 Arditti FD, Aviner S, Dekel B, Krauthgamer R, Gan J, Nagler A, Tabilio A, Martelli M, Berrebi A, Reisner Y. Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs. Blood. 105: 3365-71. PMID 15238417 DOI: 10.1182/blood-2003-03-0982  0.44
2004 Dekel B, Reisner Y. Engraftment of human early kidney precursors. Transplant Immunology. 12: 241-7. PMID 15157918 DOI: 10.1016/j.trim.2003.12.007  0.44
2004 Dekel B, Reisner Y. Embryonic committed stem cells as a solution to kidney donor shortage. Expert Opinion On Biological Therapy. 4: 443-54. PMID 15102595 DOI: 10.1517/14712598.4.4.443  0.44
2003 Sthoeger Z, Zinger H, Dekel B, Arditi F, Reisner Y, Mozes E. Lupus manifestations in severe combined immunodeficient (SCID) mice and in human/mouse radiation chimeras. Journal of Clinical Immunology. 23: 91-9. PMID 12757261  0.44
2003 Dekel B, Burakova T, Arditti FD, Reich-Zeliger S, Milstein O, Aviel-Ronen S, Rechavi G, Friedman N, Kaminski N, Passwell JH, Reisner Y. Human and porcine early kidney precursors as a new source for transplantation. Nature Medicine. 9: 53-60. PMID 12496960 DOI: 10.1038/nm812  0.44
2002 Arditti FD, Greenberg R, Dekel B, Marcus H, Nagler A, Berrebi A, Skornick Y, Reisner Y. Human colon adenocarcinoma in the SCID/CB6 radiation chimera is susceptible to adoptive transfer of allogeneic human peripheral blood mononuclear cells. Journal of Hematotherapy & Stem Cell Research. 11: 883-93. PMID 12590703 DOI: 10.1089/152581602321080547  0.44
2002 Dekel B, Amariglio N, Kaminski N, Schwartz A, Goshen E, Arditti FD, Tsarfaty I, Passwell JH, Reisner Y, Rechavi G. Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development. Journal of the American Society of Nephrology : Jasn. 13: 977-90. PMID 11912257  0.44
2002 Marcus H, Dekel B, Arditti FD, Reich-Zeliger S, Segal H, Bocher WO, Reisner Y. T cells from newborn humans are fully capable of developing into cytotoxic T lymphocyte effector cells in adoptive hosts. Transplantation. 73: 803-10. PMID 11907431  0.44
2002 Martelli MF, Reisner Y. Haploidentical 'megadose' CD34+ cell transplants for patients with acute leukemia Leukemia. 16: 404-405. PMID 11896548 DOI: 10.1038/sj.leu.2402382  0.64
2001 Böcher WO, Dekel B, Schwerin W, Geissler M, Hoffmann S, Rohwer A, Arditti F, Cooper A, Bernhard H, Berrebi A, Rose-John S, Shaul Y, Galle PR, Löhr HF, Reisner Y. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection. European Journal of Immunology. 31: 2071-9. PMID 11449360 DOI: 10.1002/1521-4141(200107)31:7<2071::AID-IMMU2071>3.0.CO;2-D  0.64
2000 Elhasid R, Ben Arush MW, Katz T, Gan Y, Shechter Y, Sami I, Postovsky S, Reisner Y, Rowe JM. Successful haploidentical bone marrow transplantation in Fanconi anemia Bone Marrow Transplantation. 26: 1221-1223. PMID 11149735 DOI: 10.1038/sj.bmt.1702701  0.64
2000 Reisner Y, Martelli MF. Tolerance induction by 'megadose' transplants of CD34+ stem cells: A new option for leukemia patients without an HLA-matched donor Current Opinion in Immunology. 12: 536-541. PMID 11007356 DOI: 10.1016/S0952-7915(00)00135-7  0.64
2000 Eren R, Ilan E, Nussbaum O, Lubin I, Terkieltaub D, Arazi Y, Ben-Moshe O, Kitchinzky A, Berr S, Gopher J, Zauberman A, Galun E, Shouval D, Daudi N, Eid A, ... ... Reisner Y, et al. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees Hepatology. 32: 588-596. PMID 10960454 DOI: 10.1053/JHEP.2000.9632  0.64
2000 Reisner Y, Martelli MF. Transplantation tolerance induced by 'mega dose' CD34+ cell transplants Experimental Hematology. 28: 119-127. PMID 10706067 DOI: 10.1016/S0301-472X(99)00132-0  0.64
1999 Reisner Y, Martelli MF. Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients Immunology Today. 20: 343-347. PMID 10431152 DOI: 10.1016/S0167-5699(98)01428-5  0.64
1999 Ilan E, Burakova T, Dagan S, Nussbaum O, Lubin I, Eren R, Ben-Moshe O, Arazi J, Berr S, Neville L, Yuen L, Mansour TS, Gillard J, Eid A, Jurim O, ... ... Reisner Y, et al. The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents. Hepatology (Baltimore, Md.). 29: 553-62. PMID 9918935 DOI: 10.1002/hep.510290228  0.64
1998 Dekel B, Marcus H, Shenkman B, Shimoni A, Shechter Y, Canaan A, Berrebi A, Varon D, Reisner Y. Human/BALB radiation chimera engrafted with splenocytes from patients with idiopathic thrombocytopenic purpura produce human platelet antibodies Immunology. 94: 410-416. PMID 9767425 DOI: 10.1046/j.1365-2567.1998.00516.x  0.64
1995 Reisner Y, Martelli MF. Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells Immunology Today. 16: 437-440. PMID 7546208 DOI: 10.1016/0167-5699(95)80021-2  0.64
1992 Lapidot T, Faktorowich Y, Lubin I, Reisner Y. Enhancement of T-cell-depleted bone marrow allografts in the absence of graft-versus-host disease is mediated by CD8+ CD4- and not by CD8- CD4+ thymocytes Blood. 80: 2406-2411. PMID 1421412  0.64
1991 Bachar-Lustig E, Gan Y, Reisner Y. Purification in large amounts of β-d-galactoside-binding lectins from a murine thymic epithelial cell line Carbohydrate Research. 213: 345-352. PMID 1933950 DOI: 10.1016/S0008-6215(00)90622-0  0.64
1991 Lubin I, Faktorowich Y, Lapidot T, Gan Y, Eshhar Z, Gazit E, Levite M, Reisner Y. Engraftment and development of human T and B cells in mice after bone marrow transplantation Science. 252: 427-431. PMID 1826797 DOI: 10.1126/science.1826797  0.64
1990 Salomon O, Lapidot T, Terenzi A, Lubin I, Rabi I, Reisner Y. Induction of donor-type chimerism in murine recipients of bone marrow allografts by different radiation regimens currently used in treatment of leukemia patients Blood. 76: 1872-1878. PMID 2224135  0.64
1990 Lapidot T, Lubin I, Terenzi A, Faktorowich Y, Erlich P, Reisner Y. Enhancement of bone marrow allografts from nude mice into mismatched recipients by T cells void of graft-versus-host activity Proceedings of the National Academy of Sciences of the United States of America. 87: 4595-4599. PMID 2191295 DOI: 10.1073/pnas.87.12.4595  0.64
1990 Terenzi A, Lubin I, Lapidot T, Salomon O, Faktorowich Y, Rabi I, Martelli MF, Reisner Y. Enhancement of T cell-depleted bone marrow allografts in mice by thiotepa Transplantation. 50: 717-720. PMID 2120811  0.64
1989 Lapidot T, Terenzi A, Singer TS, Salomon O, Reisner Y. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts. Blood. 73: 2025-32. PMID 2653469  0.64
1986 O'Reilly RJ, Brochstein J, Collins N, Keever C, Kapoor N, Kirkpatrick D, Kernan N, Dupont B, Burns J, Reisner Y. Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency. Vox Sanguinis. 51: 81-6. PMID 3532540 DOI: 10.1111/j.1423-0410.1986.tb02013.x  0.64
1983 Good RA, Kapoor N, Reisner Y. Bone marrow transplantation-An expanding approach to treatment of many diseases Cellular Immunology. 82: 36-54. PMID 6357489 DOI: 10.1016/0008-8749(83)90139-9  0.64
1980 Reisner Y, Sharon N, Haran-Ghera N. Expression of peanut agglutinin receptors on virus-induced preleukemic cells in mice Proceedings of the National Academy of Sciences of the United States of America. 77: 2244-2246. PMID 6246529 DOI: 10.1073/pnas.77.4.2244  0.64
1980 Reisner Y, Sharon N. Cell fractionation by lectins Trends in Biochemical Sciences. 5: 29-31. DOI: 10.1016/S0968-0004(80)80090-9  0.64
1979 Rabinovich H, Umiel T, Reisner Y, Sharon N, Globerson A. Characterization of embryonic liver suppressor cells by peanut agglutinin. Cellular Immunology. 47: 347-55. PMID 158436 DOI: 10.1016/0008-8749(79)90344-7  0.64
1979 Globerson A, Rabinowich H, Umiel T, Reisner Y, Sharon N. Characterization of reactive and suppressive cells in the mouse embryonic liver by peanut agglutinin (PNA). Advances in Experimental Medicine and Biology. 114: 345-50. PMID 157055 DOI: 10.1007/978-1-4615-9101-6_55  0.64
1977 Reisner Y, Gachelin G, Dubois P, Nicolas JF, Sharon N, Jacob F. Interaction of peanut agglutinin, a lectin specific for nonreducing terminal D-galactosyl residues, with embryonal carcinoma cells. Developmental Biology. 61: 20-7. PMID 924023 DOI: 10.1016/0012-1606(77)90338-4  0.64
1976 Reisner Y, Ravid A, Sharon N. Use of soybean agglutinin for the separation of mouse B and T lymphocytes Biochemical and Biophysical Research Communications. 72: 1585-1591. PMID 11794 DOI: 10.1016/S0006-291X(76)80195-7  0.64
1976 Reisner Y, Linker-Israeli M, Sharon N. Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin Cellular Immunology. 25: 129-134. PMID 9202 DOI: 10.1016/0008-8749(76)90103-9  0.64
Low-probability matches
2011 Ophir E, Eidelstein Y, Bachar-Lustig E, Hagin D, Or-Geva N, Lask A, Reisner Y. Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: the role of ex-vivo generated donor CD8+ T cells with central memory phenotype. Best Practice & Research. Clinical Haematology. 24: 393-401. PMID 21925092 DOI: 10.1016/j.beha.2011.05.007  0.28
2011 Lask A, Goichberg P, Cohen A, Goren-Arbel R, Milstein O, Aviner S, Feine I, Ophir E, Reich-Zeliger S, Hagin D, Klein T, Nagler A, Berrebi A, Reisner Y. TCR-independent killing of B cell malignancies by anti-third-party CTLs: the critical role of MHC-CD8 engagement. Journal of Immunology (Baltimore, Md. : 1950). 187: 2006-14. PMID 21753148 DOI: 10.4049/jimmunol.1100095  0.28
2010 Reich-Zeliger S, Eidelstein Y, Hagin D, Antebi YE, Seger R, Reisner Y. Deletion of alloreactive T cells by veto cytotoxic T lymphocytes is mediated through extracellular signal-regulated kinase phosphorylation. Transplantation. 90: 380-6. PMID 20595932 DOI: 10.1097/TP.0b013e3181e86b28  0.28
2010 Ophir E, Eidelstein Y, Afik R, Bachar-Lustig E, Reisner Y. Induction of tolerance to bone marrow allografts by donor-derived host nonreactive ex vivo-induced central memory CD8 T cells. Blood. 115: 2095-104. PMID 20042725 DOI: 10.1182/blood-2009-10-248716  0.28
2007 Reich-Zeliger S, Bachar-Lustig E, Bar-Ilan A, Reisner Y. Tolerance induction in presensitized bone marrow recipients by veto CTLs: effective deletion of host anti-donor memory effector cells. Journal of Immunology (Baltimore, Md. : 1950). 179: 6389-94. PMID 17982025  0.28
2005 Aviner S, Yao X, Krauthgamer R, Gan Y, Goren-Arbel R, Klein T, Tabilio A, McMannis JD, Champlin R, Martelli MF, Bachar-Lustig E, Reisner Y. Large-scale preparation of human anti-third-party veto cytotoxic T lymphocytes depleted of graft-versus-host reactivity: a new source for graft facilitating cells in bone marrow transplantation. Human Immunology. 66: 644-52. PMID 15993710 DOI: 10.1016/j.humimm.2005.03.004  0.28
2005 Reisner Y, Gur H, Reich-Zeliger S, Martelli MF, Bachar-Lustig E. Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells. Annals of the New York Academy of Sciences. 1044: 70-83. PMID 15958699 DOI: 10.1196/annals.1349.010  0.28
2004 Reich-Zeliger S, Gan J, Bachar-Lustig E, Reisner Y. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. II. Deletion of effector cells by Fas-Fas ligand apoptosis. Journal of Immunology (Baltimore, Md. : 1950). 173: 6660-6. PMID 15557157  0.28
2004 Reich-Zeliger S, Bachar-Lustig E, Gan J, Reisner Y. Tolerance induction by veto CTLs in the TCR transgenic 2C mouse model. I. Relative reactivity of different veto cells. Journal of Immunology (Baltimore, Md. : 1950). 173: 6654-9. PMID 15557156  0.28
2004 Reisner Y, Gur H, Reich-Zeliger S, Martelli MF, Bachar-Lustig E. Crossing the HLA barriers. Blood Cells, Molecules & Diseases. 33: 206-10. PMID 15528132 DOI: 10.1016/j.bcmd.2004.08.004  0.28
2003 Reisner Y, Gur H, Reich-Zeliger S, Martelli MF, Bachar-Lustig E. Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells. Annals of the New York Academy of Sciences. 996: 72-9. PMID 12799285  0.28
2003 Bachar-Lustig E, Reich-Zeliger S, Reisner Y. Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose. Blood. 102: 1943-50. PMID 12775573 DOI: 10.1182/blood-2003-03-0759  0.28
2016 Orgad R, Nathansohn-Levi B, Kagan S, Zlotnikov Klionsky Y, Reisner Y. Erratum to: Novel immunoregulatory role of perforin-positive dendritic cells. Seminars in Immunopathology. PMID 27858143 DOI: 10.1007/s00281-016-0598-5  0.24
2008 Milstein O, Tseng SY, Starr T, Llodra J, Nans A, Liu M, Wild MK, van der Merwe PA, Stokes DL, Reisner Y, Dustin ML. Nanoscale increases in CD2-CD48-mediated intermembrane spacing decrease adhesion and reorganize the immunological synapse. The Journal of Biological Chemistry. 283: 34414-22. PMID 18826951 DOI: 10.1074/jbc.M804756200  0.2
2017 Aversa F, Bachar-Lustig E, Or-Geva N, Prezioso L, Bonomini S, Manfra I, Monti A, Schifano C, Zlotnikov-Klionsky Y, Martelli MF, Sammarelli G, Sassi M, Soli M, Giuliodori S, Benecchi M, ... ... Reisner Y, et al. Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide. Blood Advances. 1: 2166-2175. PMID 29296864 DOI: 10.1182/bloodadvances.2017009423  0.16
2017 Or-Geva N, Gidron-Budovsky R, Radomir L, Edelstein Y, Singh AK, Sidlik-Muskatel R, Ophir E, Bachar-Lustig E, Reisner Y. Towards 'off-the-shelf' genetically modified T-Cells: Prolonging functional engraftment in mice by CD8 veto T-cells. Leukemia. PMID 29151584 DOI: 10.1038/leu.2017.332  0.16
2002 Martelli MF, Aversa F, Bachar-Lustig E, Velardi A, Reich-Zelicher S, Tabilio A, Gur H, Reisner Y. Transplants across human leukocyte antigen barriers. Seminars in Hematology. 39: 48-56. PMID 11799529  0.16
1997 Dekel B, Burakova T, Shezen E, Marcus H, Canaan A, Reisner Y. Human renal allograft rejection in the SCID/rat radiation chimera. Transplantation Proceedings. 29: 2255-6. PMID 9193613 DOI: 10.1016/S0041-1345(97)00319-9  0.16
2010 Hagin D, Reisner Y. Haploidentical bone marrow transplantation in primary immune deficiency: stem cell selection and manipulation. Immunology and Allergy Clinics of North America. 30: 45-62. PMID 20113886 DOI: 10.1016/j.iac.2009.11.002  0.12
2008 De Ioanni M, Di Ianni M, Bonifacio E, Moretti L, Cecchini D, Bazzucchi F, Terenzi A, Aloisi T, Falzetti F, Aversa F, Reisner Y, Martelli MF, Tabilio A. Large-scale generation of human allodepleted anti-3rd party lymphocytes. Blood Cells, Molecules & Diseases. 40: 106-12. PMID 17931916 DOI: 10.1016/j.bcmd.2007.07.014  0.12
2005 Aversa F, Terenzi A, Tabilio A, Falzetti F, Carotti A, Ballanti S, Felicini R, Falcinelli F, Velardi A, Ruggeri L, Aloisi T, Saab JP, Santucci A, Perruccio K, Martelli MP, ... ... Reisner Y, et al. Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 3447-54. PMID 15753458 DOI: 10.1200/JCO.2005.09.117  0.12
2005 Arditti FD, Rabinkov A, Miron T, Reisner Y, Berrebi A, Wilchek M, Mirelman D. Apoptotic killing of B-chronic lymphocytic leukemia tumor cells by allicin generated in situ using a rituximab-alliinase conjugate. Molecular Cancer Therapeutics. 4: 325-31. PMID 15713903  0.12
2004 Aversa F, Berneman ZN, Locatelli F, Martelli MF, Reisner Y, Tabilio A, Velardi A, Vuk-Pavlovic S. Fourth International Workshop on Haploidentical Transplants, Naples, Italy, July 8-10, 2004. Blood Cells, Molecules & Diseases. 33: 159-75. PMID 15580686  0.12
2002 Gur H, Krauthgamer R, Berrebi A, Klein T, Nagler A, Tabilio A, Martelli MF, Reisner Y. Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells. Blood. 99: 4174-81. PMID 12010823  0.12
2011 Hagin D, Reisner Y. Haploidentical bone marrow transplantation in primary immune deficiency: stem cell selection and manipulation. Hematology/Oncology Clinics of North America. 25: 45-62. PMID 21236389 DOI: 10.1016/j.hoc.2010.11.004  0.08
2001 Bachar-Lustig E, Reich-Zeliger S, Gur H, Zhao Y, Krauthgamer R, Reisner Y. Bone marrow transplantation across major genetic barriers: the role of megadose stem cells and nonalloreactive donor anti-third party CTLS. Transplantation Proceedings. 33: 2099-100. PMID 11377465 DOI: 10.1016/S0041-1345(01)01962-5  0.08
2016 Orgad R, Nathansohn-Levi B, Kagan S, Reisner Y. Novel immunoregulatory role of perforin-positive dendritic cells. Seminars in Immunopathology. PMID 27577575 DOI: 10.1007/s00281-016-0589-6  0.04
2012 Ophir E, Reisner Y. The use of donor-derived veto cells in hematopoietic stem cell transplantation. Frontiers in Immunology. 3: 93. PMID 22566971 DOI: 10.3389/fimmu.2012.00093  0.04
2011 Di Ianni M, Falzetti F, Carotti A, Terenzi A, Del Papa B, Perruccio K, Ruggeri L, Sportoletti P, Rosati E, Marconi P, Falini B, Reisner Y, Velardi A, Aversa F, Martelli MF. Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. Best Practice & Research. Clinical Haematology. 24: 459-66. PMID 21925099 DOI: 10.1016/j.beha.2011.05.005  0.04
2011 Reisner Y, Hagin D, Martelli MF. Haploidentical hematopoietic transplantation: current status and future perspectives. Blood. 118: 6006-17. PMID 21921045 DOI: 10.1182/blood-2011-07-338822  0.04
2011 Di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, Bonifacio E, Del Papa B, Zei T, Ostini RI, Cecchini D, Aloisi T, Perruccio K, Ruggeri L, Balucani C, Pierini A, ... ... Reisner Y, et al. Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood. 117: 3921-8. PMID 21292771 DOI: 10.1182/blood-2010-10-311894  0.04
2008 Aversa F, Reisner Y, Martelli MF. The haploidentical option for high-risk haematological malignancies. Blood Cells, Molecules & Diseases. 40: 8-12. PMID 17905610 DOI: 10.1016/j.bcmd.2007.07.004  0.04
2004 Aversa F, Reisner Y, Martelli MF. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia. Blood Cells, Molecules & Diseases. 33: 294-302. PMID 15528148 DOI: 10.1016/j.bcmd.2004.08.021  0.04
2000 Reich-Zeliger S, Zhao Y, Krauthgamer R, Bachar-Lustig E, Reisner Y. Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite. Immunity. 13: 507-15. PMID 11070169 DOI: 10.1016/S1074-7613(00)00050-9  0.04
1999 Bachar-Lustig E, Li HW, Marcus H, Reisner Y. Tolerance induction by megadose stem cell transplants: synergism between SCA-1+ Lin- cells and nonalloreactive T cells. Transplantation Proceedings. 30: 4007-8. PMID 9865277 DOI: 10.1016/S0041-1345(98)01320-7  0.04
1996 Marcus H, Burakova T, Shezen E, David M, Canaan A, Lubin I, Reisner Y. Human-->mouse radiation chimera do not develop Epstein-Barr virus lymphoma. Immunology Letters. 49: 155-61. PMID 8739310 DOI: 10.1016/0165-2478(96)02497-2  0.04
1996 Bachar-Lustig E, Rachamim N, Li HW, Lan F, Reisner Y. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. Nature Medicine. 1: 1268-73. PMID 7489407 DOI: 10.1038/nm1295-1268  0.04
2021 Singh AK, Schetzen E, Yadav SK, Lustig EB, Liu WH, Yadav RK, Gale RP, McGinnis K, Reisner Y. Correction of murine sickle cell disease by allogeneic haematopoietic cell transplantation with anti-3rd party veto cells. Bone Marrow Transplantation. PMID 33658643 DOI: 10.1038/s41409-021-01237-6  0.01
2019 Reisner Y. Haploidentical HSCT-going from strength to strength. Bone Marrow Transplantation. 54: 687-688. PMID 31431721 DOI: 10.1038/s41409-019-0593-2  0.01
2019 Sidlik-Muskatel R, Reisner Y. Toward safer haploidnetical hematopoietic stem cell transplantation. Bone Marrow Transplantation. 54: 733-737. PMID 31431713 DOI: 10.1038/s41409-019-0595-0  0.01
2019 Reisner Y, Or-Geva N. Veto cells for safer nonmyeloablative haploidentical HSCT and CAR T cell therapy. Seminars in Hematology. 56: 173-182. PMID 31202427 DOI: 10.1053/j.seminhematol.2019.03.003  0.01
2019 Or-Geva N, Gidron-Budovsky R, Sidlik-Muskatel R, Singh AK, Reisner Y. Next-generation CD8 memory veto T cells directed against memory antigens. Leukemia. PMID 31189891 DOI: 10.1038/s41375-019-0501-1  0.01
2019 Singh AK, Schetzen E, Lustig EB, Liu W, Yadav RK, Yadav SK, McGinnis K, Reisner Y. Proof of Concept for Repair of Sickle Cell Disease By Non-Myeloablative MHC Disparate T Cell Depleted HSCT Combined with Donor-Derived Veto Cells Blood. 134: 1919-1919. DOI: 10.1182/blood-2019-124594  0.01
2018 Al Malki M, Jones R, Ma Q, Lee D, Reisner Y, Miller JS, Lang P, Hongeng S, Hari P, Strober S, Yu J, Maziarz R, Mavilio D, Roy DC, Bonini C, et al. Proceedings From the Fourth Haploidentical Stem Cell Transplantation Symposium - HAPLO2016, San Diego, California, December 1, 2016. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 29339270 DOI: 10.1016/j.bbmt.2018.01.008  0.01
2018 Marcu A, Trautwein N, Stevanovic S, Johann P, Technau A, Lager J, Monoranu C, Henkel L, Krauß J, Ebinger M, Schuhmann M, Thomale U, Pietsch T, Wölfl M, Schlegel PG, ... ... Reisner Y, et al. IMMU-28. DECIPHERING THE AT/RT LIGANDOME Neuro-Oncology. 20: i104-i104. DOI: 10.1093/neuonc/noy059.344  0.01
2016 Chakrabarti S, Aversa F, Reisner Y, O'Donnell P. Haploidentical Family Donor Transplantation: At the Crossroads of a Changing Paradigm. Advances in Hematology. 2016: 9753542. PMID 27340406 DOI: 10.1155/2016/9753542  0.01
2016 Or-Geva N, Reisner Y. The evolution of T-cell depletion in haploidentical stem-cell transplantation. British Journal of Haematology. 172: 667-84. PMID 26684279 DOI: 10.1111/bjh.13868  0.01
2016 Or-Geva N, Reisner Y. The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT. Bone Marrow Transplantation. S14-20. PMID 26039201 DOI: 10.1038/bmt.2015.89  0.01
2016 Aversa F, BacharLustig E, Prezioso L, Bonomini S, Or Geva N, Monti A, Manfra I, Schifano C, Galaverna F, Zlotnikov Klionsky Y, Reisner Y. Transplantation of T Cell Depleted Haploidentical HSCT Following Non-Myeloablative (NMA) Conditioning: Combining the Power of Megadose Transplants with Post Transplant Cyclophosphamide (PTCY) Blood. 128: 5765-5765. DOI: 10.1182/blood.V128.22.5765.5765  0.01
2016 Bachar Lustig E, Or Geva N, Lask A, Gidron R, Kagan S, Kumar Sinqh A, Reisner Y. Next Generation Veto Cells for Non-Myeloablative Haploidentical HSCT: Combining Anti-Viral and Graft Facilitating Activity Blood. 128: 3345-3345. DOI: 10.1182/BLOOD.V128.22.3345.3345  0.01
2016 Or Geva N, Gidron R, Singh AK, Sidlik Muskatel R, Reisner Y. Towards 'Off-the-Shelf ' Universal Chimeric Antigen Receptor (CAR) T Cells: Mouse Anti-3rd Party Central Memory CD8 Veto Cells Prolong Functional Engraftment of Allogeneic Genetically Modified T Cells Blood. 128: 2171-2171. DOI: 10.1182/BLOOD.V128.22.2171.2171  0.01
2016 Hillel Karniel C, Rosen C, Bachar Lustig E, Shezen E, Reisner Y. High Levels of Hematopoietic Progenitors in the Fetal Lung Enable Induction of Immune Tolerance and Co-Transplantation of Epithelial Progenitors for Repair of Lung Injury Across MHC Barriers Blood. 128: 1477-1477. DOI: 10.1182/blood.v128.22.1477.1477  0.01
2015 Or-Geva N, Reisner Y. Exercising 'veto' power to make haploidentical hematopoietic stem cell transplantation a safe modality for induction of immune tolerance. Regenerative Medicine. 10: 239-42. PMID 25933232 DOI: 10.2217/rme.14.94  0.01
2014 Or-Geva N, Reisner Y. Megadose stem cell administration as a route to mixed chimerism. Current Opinion in Organ Transplantation. 19: 334-41. PMID 24905022 DOI: 10.1097/MOT.0000000000000095  0.01
2013 Klionsky YZ, Nathansohn B, Rosen C, Aronovich A, Jung S, Shezen E, Yifa O, Reisner Y. Perforin Positive Regulatory DCs In Immune Tolerance: Novel Anti-Inflammatory Players In Metabolic Syndrome Blood. 122: 784-784. DOI: 10.1182/blood.v122.21.784.784  0.01
2013 Bachar-Lustig E, Or-Geva N, Klionsky YZ, Reisner Y. Chimerism Induction Without GVHD Following Low Intensity Conditioning In MHC Disparate Recipients: Combining The Benefit Of Cyclophosphamide Post Transplant With The Tolerogenicity Of Megadose T Cell Depleted HSCT Blood. 122: 3238-3238. DOI: 10.1182/blood.v122.21.3238.3238  0.01
2011 Aronovich A, Nur Y, Rosen C, Klionsky Y, Yarimi L, Hagin D, Rechavi G, Martinowitz U, Tchorsh–Yutsis D, Reisner Y. Hematopoietic Size Control: A Novel Role for Factor VIII Via the Thrombin/PAR1 Axis in Regulating the Interplay Between Dynamic Bone Structure and Long Term Survival and Mobilization of Hematopoietic Stem Cells Blood. 118: 19-19. DOI: 10.1182/blood.v118.21.19.19  0.01
2011 Di Ianni M, Falzetti F, Carotti A, Terenzi A, Ruggeri L, Antonio P, de Fazio V, Zoi V, Massei MS, Reisner Y, Velardi A, Aversa F, Martelli MF. Adoptive Immunotherapy with Tregs and Tcons Ensures Low TRM and a Low Incidence of Post Transplant Leukaemia Relapse After HLA Haploidentical Transplants for Acute Leukemia Blood. 118: 154-154. DOI: 10.1182/BLOOD.V118.21.154.154  0.01
2011 Ophir E, Or-geva N, Lask A, Margalit R, Cohen Fredarow A, Afik R, Hagin D, Eidelstein Y, Negrin R, Bachar-Lustig E, Reisner Y. The Double Benefit of ex-vivo Generated Anti 3rd Party CD8 T Cells With Central Memory Phenotype: Enhanced BM Engraftment Coupled With Marked GVL in the Absence of GVHD Biology of Blood and Marrow Transplantation. 17: S287-S288. DOI: 10.1016/j.bbmt.2010.12.406  0.01
2010 Huang Z, Yang J, Luo G, Gan C, Cheng W, Yuan S, Peng X, Tan J, Wang X, Hu J, Yang S, Reisner Y, Ge L, Wei H, Cheng P, et al. Embryonic porcine skin precursors can successfully develop into integrated skin without teratoma formation posttransplantation in nude mouse model. Plos One. 5: e8717. PMID 20090918 DOI: 10.1371/journal.pone.0008717  0.01
2010 Lask A, Ophir E, Or-Geva N, Cohen A, Afik R, Eidelstein Y, Negrin R, Nagler A, Berrebi A, Hagin D, Reisner Y. Ex Vivo Generated Donor Central Memory CD8 T Cells, Previously Shown to Enhance Engraftment of Allogeneic Bone Marrow, Also Exhibit Significant GVL Activity without Causing Gvhd In An In Vivo b Cell Lymphoma Model Blood. 116: 424-424. DOI: 10.1182/BLOOD.V116.21.424.424  0.01
2010 Bachar-Lustig E, Tchorsh-Yutsis D, Ophir E, Klionsky YZ, Or-Geva N, Reisner Y. Towards Clinically Feasible Co-Stimulatory Blockade for Tolerance Induction: Transient Treatment with CTLA4-Ig, Anti-CD48 and FTY720 Enables Durable Engraftment of T Cell Depleted BM Allografts Following Non-Myeloablative Conditioning. Blood. 116: 3726-3726. DOI: 10.1182/blood.V116.21.3726.3726  0.01
2009 Ophir E, Reisner Y. Induction of tolerance in organ recipients by hematopoietic stem cell transplantation. International Immunopharmacology. 9: 694-700. PMID 19150657 DOI: 10.1016/j.intimp.2008.12.009  0.01
2009 Zangi L, Edelshtein Y, Klionsky Y, Bachar-Lustig E, Shezen E, Reich-Zeliger S, Lask A, Milstein O, Shinder V, Reisner Y. Tolerance Induction by Immature Dendritic Cells Is Mediated by Distinct MHC Dependent and Independent Mechanisms: A Novel Role for Perforin, Granzyme A and Toll Like Receptor 7. Blood. 114: 65-65. DOI: 10.1182/BLOOD.V114.22.65.65  0.01
2009 Di Ianni M, Falzetti F, Carotti A, Terenzi A, Bonifacio E, Reisner Y, Velardi A, Aversa F, Martelli MF. Adoptive Immunotherapy with Tregs Prevents GvHD and Favours Immune Reconstitution After HLA Haploidentical Transplants for Hematological Malignancies. Blood. 114: 4-4. DOI: 10.1182/blood.v114.22.4.4  0.01
2008 Aronovich A, Tchorsh D, Shezen E, Rosen C, Klionsky Y, Cohen S, Tal O, Martinovich U, Katchman H, Eventov-Friedman S, Amariglio N, Jacob-Hirsch J, Rechavi G, Reisner Y. A Novel Role for Factor VIII and Other Coagulation Factors in Organ Size Control Blood. 112: 592-592. DOI: 10.1182/blood.V112.11.592.592  0.01
2008 Zangi L, Beilhack A, Negrin R, Margalit R, Reisner Y. Mesenchymal Stem Cells (MSC) Are Not Intrinsically Immune Privileged: Direct Demonstration in TCR Transgenic Mice and by Imaging of Allogeneic Luciferase+ MSC in Immune Competent Vs Immune Deficient Mice Blood. 112: 549-549. DOI: 10.1182/BLOOD.V112.11.549.549  0.01
2008 Elhasid R, Zaidman I, Abdalla K, Ben-Arush M, Haddad N, Zuckerman T, Gidoni O, Rubin D, Katz R, Polack S, Reisner Y, Rowe JM. Successful Long- Term Outcome and Chimeric Status Following Allogeneic Stem Cell Transplantation for Non-Malignant Disorders Using Moderate T Cell Depletion with No Post Transplant Gvhd Prophylaxis. Blood. 112: 3292-3292. DOI: 10.1182/blood.v112.11.3292.3292  0.01
2008 Edelshtein Y, Ophir E, Bachar-Lustig E, Afik R, Reisner Y. Ex-Vivo Acquisition of Central Memory Phenotype Is Critical for Tolerance Induction by Donor Anti-3rd party CD8 T Cells in Allogeneic Bone Marrow Transplantation. Blood. 112: 2323-2323. DOI: 10.1182/BLOOD.V112.11.2323.2323  0.01
2007 Reisner Y. Growing organs for transplantation from embryonic precursor tissues. Immunologic Research. 38: 261-73. PMID 17917031  0.01
2007 Reisner Y. Hematopoietic stem cell transplantation across major genetic barriers. Immunologic Research. 38: 174-90. PMID 17917024  0.01
2007 Elhasid R, Arush MB, Zaidman I, Leiba R, Barak AB, Postovsky S, Haddad N, Katz T, Pollack S, Sami I, Gidoni O, Rubin D, Mandel H, Attias D, Reisner Y, et al. Safe and efficacious allogeneic bone marrow transplantation for nonmalignant disorders using partial T cell depletion and no posttransplantation graft-versus-host-disease prophylaxis. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 13: 329-38. PMID 17317586 DOI: 10.1016/j.bbmt.2006.10.028  0.01
2007 Reich-zeliger S, Edelshtein Y, Hagin D, Seger R, Reisner Y. The Role of ERK and XIAP in Tolerance Induction by Veto CTLs. Blood. 110: 3256-3256. DOI: 10.1182/blood.v110.11.3256.3256  0.01
2007 Lask A, Goichberg P, Goren-Arbel R, Milstein O, Aviner S, Feine I, Klein T, Berrebi A, Reisner Y. Eradication of B Cell Malignancies by Anti-3rd Party CTLs: A Novel Role for MHC Class I. Blood. 110: 2759-2759. DOI: 10.1182/BLOOD.V110.11.2759.2759  0.01
2007 Milstein O, Lask A, Reich-Zeliger S, Reisner Y. A Novel Mechanism for CTL Mediated Veto Activity: CTLs Respond to Recognition by Alloreactive T Cell with Activation and Cytotoxic Granule Secretion. Blood. 110: 2303-2303. DOI: 10.1182/BLOOD.V110.11.2303.2303  0.01
2006 REISNER Y. Stem Cell Transplantation across Major Genetic Barriers Annals of the New York Academy of Sciences. 938: 322-327. DOI: 10.1111/J.1749-6632.2001.TB03600.X  0.01
2006 Reisner Y, Shlomit R, Bachar-Lustig E. The role of veto cells in bone marrow transplantation Current Opinion in Organ Transplantation. 11: 366-372. DOI: 10.1097/01.mot.0000236698.45210.3e  0.01
2005 Ayash-Rashkovsky M, Bentwich Z, Arditti F, Friedman S, Reisner Y, Borkow G. A novel small animal model for HIV-1 infection. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 19: 1149-51. PMID 15833767 DOI: 10.1096/fj.04-3184fje  0.01
2005 Steiner D, Brunicki N, Bachar-Lustig E, Reisner Y. Overcoming Rejection of Bone Marrow Allografts by Treg Cells in a Stringent Mouse Model for T Cell Mediated Rejection: Tolerance Induction by Third Party “Off-the-Shelf” Cells. Blood. 106: 576-576. DOI: 10.1182/blood.v106.11.576.576  0.01
2005 Aversa F, Tabilio A, Terenzi A, Ballanti S, Carotti A, Falzetti F, Velardi A, Aloisi T, Flenghi L, Saab JP, Reisner YM, Martelli MF. Hematopoietic Stem Cell Transplantation (HSCT) from Alternative Donors for Acute Leukemia at High-Risk of Relapse. The Haploidentical Option. Blood. 106: 441-441. DOI: 10.1182/blood.v106.11.441.441  0.01
2005 Reich-Zeliger S, Hanoch T, Seger R, Reisner Y. The Role of ERK5 Signaling in Tolerance Induction by Veto CTLs. Blood. 106: 3302-3302. DOI: 10.1182/BLOOD.V106.11.3302.3302  0.01
2005 Reisner Y. ICOS: a new important player in BMT Blood. 105: 3006-3007. DOI: 10.1182/BLOOD-2005-01-0384  0.01
2004 Reich-Zeliger S, Bachar-Lustig E, Reisner Y. Effective Deletion of Anti-Donor Host Memory Effector Cells by Anti-3rd Party Veto CTLs: Implications to Tolerance Induction in Presensitized Bone Marrow Recipients. Blood. 104: 44-44. DOI: 10.1182/BLOOD.V104.11.44.44  0.01
2004 Aviner S, Arditti FD, Arbel-Goren R, Klein T, Reisner Y. Eradication of B-Lymphoma by Allogeneic Anti-Third Party Host Non-Reactive CTLs: Growing Evidence for TCR Independent Reactivity Against B-Cell Malignancies. Blood. 104: 3055-3055. DOI: 10.1182/blood.v104.11.3055.3055  0.01
2004 Aviner S, Bachar-Lustig E, Brouard S, Goren R, Guillet M, Soulillou J, Reisner Y. Anti-3rd party veto CTLs depleted of host reactive clones retain a broad TCR repertoire: a potential new source for adoptive immune therapy in bone marrow transplantation Biology of Blood and Marrow Transplantation. 10: 22. DOI: 10.1016/j.bbmt.2003.12.086  0.01
2003 Aversa F, Terenzi A, Ballanti S, Felicini R, Carotti A, Falcinelli F, Tabilio A, Falzetti F, Velardi A, Santucci A, Reisner Y, Martelli M. 9Improving outcomes of haploidentical transplants for acute leukemia Biology of Blood and Marrow Transplantation. 9: 65-66. DOI: 10.1016/S1083-8791(03)80010-1  0.01
2002 Champlin R, Hesdorffer C, Lowenberg B, Martelli MF, Mertelsmann RH, Reisner Y, Schmitz N. Haploidentical 'megadose' stem cell transplantation in acute leukemia: recommendations for a protocol agreed upon at the Perugia and Chicago meetings. Leukemia. 16: 427-8. PMID 11896552 DOI: 10.1038/SJ.LEU.2402386  0.01
2002 Aversa F, Velardi A, Tabilio A, Reisner Y, Martelli MF. Haploidentical stem cell transplantation in leukemia. Blood Reviews. 15: 111-9. PMID 11735159 DOI: 10.1054/BLRE.2001.0157  0.01
2002 Reisner Y, Aversa F, Bachar-Lustig E, Ruggeri L, Gur H, Velardi A, Reich-Zeliger S, Tabilio A, Martelli MF. Megadose of hematopoietic stem cells for haploidentical transplants Current Opinion in Organ Transplantation. 7: 294-298. DOI: 10.1097/00075200-200209000-00014  0.01
2000 Dekel B, Marcus H, Herzel BH, Böcher WO, Passwell JH, Reisner Y. In vivo modulation of the allogeneic immune response by human fetal kidneys: the role of cytokines, chemokines, and cytolytic effector molecules. Transplantation. 69: 1470-8. PMID 10798773 DOI: 10.1097/00007890-200004150-00044  0.01
2000 Galun E, Nahor O, Eid A, Jurim O, Rose-John S, Blum HE, Nussbaum O, Ilan E, Daudi N, Shouval D, Reisner Y, Dagan S. Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. Virology. 270: 299-309. PMID 10792989 DOI: 10.1006/VIRO.2000.0210  0.01
2000 Böcher WO, Galun E, Marcus H, Daudi N, Terkieltaub D, Shouval D, Löhr HF, Reisner Y. Reduced hepatitis B virus surface antigen-specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse. Hepatology (Baltimore, Md.). 31: 480-7. PMID 10655274 DOI: 10.1002/HEP.510310231  0.01
2000 Dekel B, Passwell JH, Reisner Y. Modulation of the immune response by fetal kidney allografts. Pediatric Nephrology (Berlin, Germany). 13: 974-9. PMID 10603160 DOI: 10.1007/s004670050739  0.01
2000 Nussbaum O, Ilan E, Eren R, Ben-Moshe O, Arazi Y, Berr S, Lubin I, Shouval D, Galun E, Reisner Y, Dagan S. The trimera mouse system: A model for HCV infection and evaluation of antiviral drugs Journal of Hepatology. 32: 172. DOI: 10.1016/S0168-8278(00)80984-8  0.01
1999 Zhao Y, Lan F, Gan J, Yao X, Reisner Y. Donor-type chimerism determination by competitive polymerase chain reaction (PCR) in a primate model for bone marrow transplantation. Transplantation. 68: 1573-7. PMID 10589957 DOI: 10.1097/00007890-199911270-00023  0.01
1999 Dekel B, Böcher WO, Marcus H, Yussim A, Reisner Y. Acute cellular rejection of human renal tissue by adoptive transfer of allogeneic human peripheral blood mononuclear cells into chimeric rats: sequential gene expression of cytokines, chemokines and cytolytic effector molecules, and their regulation by CTLA-4-Ig. International Immunology. 11: 1673-83. PMID 10508185 DOI: 10.1093/INTIMM/11.10.1673  0.01
1999 Ben-Yedidia T, Marcus H, Reisner Y, Arnon R. Intranasal administration of peptide vaccine protects human/mouse radiation chimera from influenza infection. International Immunology. 11: 1043-51. PMID 10383936 DOI: 10.1093/INTIMM/11.7.1043  0.01
1999 Reisner Y, Bachar-Lustig E, Li HW, Aversa F, Velardi A, Martelli MF. The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation. Annals of the New York Academy of Sciences. 872: 336-48; discussion 3. PMID 10372136 DOI: 10.1111/J.1749-6632.1999.TB08478.X  0.01
1999 Aversa F, Terenzi A, Carotti A, Felicini R, Jacucci R, Zei T, Latini P, Aristei C, Santucci A, Martelli MP, Cunningham I, Reisner Y, Martelli MF. Improved outcome with T-cell-depleted bone marrow transplantation for acute leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 1545-50. PMID 10334542 DOI: 10.1200/JCO.1999.17.5.1545  0.01
1999 Böcher WO, Marcus H, Shakarchy R, Dekel B, Shouval D, Galun E, Reisner Y. Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo. Immunology. 96: 634-41. PMID 10233752 DOI: 10.1046/J.1365-2567.1999.00704.X  0.01
1999 Canaan A, Marcus H, Burakova T, David M, Dekel B, Segall H, Reisner Y. T cell control of staphylococcal enterotoxin B (SEB) lethal sensitivity in mice: CD4+ CD45RB(bright)/CD4+ CD45RB(dim) balance defines susceptibility to SEB toxicity. European Journal of Immunology. 29: 1375-82. PMID 10229105 DOI: 10.1002/(SICI)1521-4141(199904)29:04<1375::AID-IMMU1375>3.0.CO;2-N  0.01
1999 Dekel B, Biton S, Passwell JH, Reisner Y, Ilan T. Met Expression in Long-Term Human Fetal Transplants Established in Immunodeficient Rats Pediatric Research. 45: 330A-330A. DOI: 10.1203/00006450-199904020-01962  0.01
1999 Bachar-Lustig E, Li HW, Gur H, Krauthgamer R, Marcus H, Reisner Y. Induction of Donor-Type Chimerism and Transplantation Tolerance Across Major Histocompatibility Barriers in Sublethally Irradiated Mice by Sca-1+Lin− Bone Marrow Progenitor Cells: Synergism With Non-Alloreactive (Host × Donor)F1 T Cells Blood. 94: 3212-3221. DOI: 10.1182/blood.v94.9.3212.421k29_3212_3221  0.01
1999 Bachar-Lustig E, Li HW, Gur H, Krauthgamer R, Marcus H, Reisner Y. Induction of Donor-Type Chimerism and Transplantation Tolerance Across Major Histocompatibility Barriers in Sublethally Irradiated Mice by Sca-1+Lin− Bone Marrow Progenitor Cells: Synergism With Non-Alloreactive (Host × Donor)F1 T Cells Blood. 94: 3212-3221. DOI: 10.1182/BLOOD.V94.9.3212  0.01
1998 Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F, Ruggeri L, Barbabietola G, Aristei C, Latini P, Reisner Y, Martelli MF. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. The New England Journal of Medicine. 339: 1186-93. PMID 9780338 DOI: 10.1056/NEJM199810223391702  0.01
1998 Reisner Y, Dagan S. The Trimera mouse: generating human monoclonal antibodies and an animal model for human diseases. Trends in Biotechnology. 16: 242-6. PMID 9652134 DOI: 10.1016/S0167-7799(98)01203-7  0.01
1998 Rachamim N, Gan J, Segall H, Krauthgamer R, Marcus H, Berrebi A, Martelli M, Reisner Y. Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture. Transplantation. 65: 1386-93. PMID 9625023 DOI: 10.1097/00007890-199805270-00017  0.01
1998 Eren R, Lubin I, Terkieltaub D, Ben-Moshe O, Zauberman A, Uhlmann R, Tzahor T, Moss S, Ilan E, Shouval D, Galun E, Daudi N, Marcus H, Reisner Y, Dagan S. Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system. Immunology. 93: 154-61. PMID 9616363 DOI: 10.1046/J.1365-2567.1998.00426.X  0.01
1998 Dekel B, Burakova T, Ben-Hur H, Marcus H, Oren R, Laufer J, Reisner Y. Engraftment of human kidney tissue in rat radiation chimera: II. Human fetal kidneys display reduced immunogenicity to adoptively transferred human peripheral blood mononuclear cells and exhibit rapid growth and development. Transplantation. 64: 1550-8. PMID 9415555 DOI: 10.1097/00007890-199712150-00008  0.01
1998 Dekel B, Burakova T, Marcus H, Shezen E, Polack S, Canaan A, Passwell J, Reisner Y. Engraftment of human kidney tissue in rat radiation chimera: I. A new model of human kidney allograft rejection. Transplantation. 64: 1541-50. PMID 9415554 DOI: 10.1097/00007890-199712150-00007  0.01
1998 Dekel B, Burakova T, Marcus H, Oren R, Bocher WO, Passwell JH, Reisner Y. In-Vivo Modulation of the Immune Response by Human Fetal Kidney • 1796 Pediatric Research. 43: 306-306. DOI: 10.1203/00006450-199804001-01819  0.01
1998 Ilan E, Nussbaum O, Lubin I, Eren R, Ben-Moshe O, Arazi J, Berr S, Neville L, Shouval D, Nahor O, Reisner Y, Dagan S, Galun E. The HBV trimera mouse: a model for human HBV infection and evaluation of anti-viral agents Journal of Hepatology. 28: 108. DOI: 10.1016/S0168-8278(98)80627-2  0.01
1998 Eren R, Ilan E, Lubin I, Terkieltaub D, Ben-Moshe O, Arazi J, Zauberman A, Nussbaum O, Berr S, Galun E, Shouval D, Daudi N, Reisner Y, Magnius L, Dagan S. Generation of high affinity, fully human monoclonal antibodies specific to hepatitis B virus in a human/mouse radiation chimera: the trimera system Journal of Hepatology. 28: 56. DOI: 10.1016/S0168-8278(98)80424-8  0.01
1997 Aversa F, Martelli MM, Reisner Y. Use of stem cells from mismatched related donors. Current Opinion in Hematology. 4: 419-22. PMID 9358999 DOI: 10.1097/00062752-199704060-00010  0.01
1997 Rachamim N, Gan J, Segall H, Marcus H, Berebi A, Krauthgamer R, Martelli M, Reisner Y. Potential role of CD34 stem cells in tolerance induction. Transplantation Proceedings. 29: 1935-6. PMID 9193461 DOI: 10.1016/S0041-1345(97)00167-X  0.01
1997 Marcus H, Shimoni A, Ergas D, Canaan A, Dekel B, Ben-David D, David M, Sigler E, Reisner Y, Berrebi A. Human/mouse radiation chimera generated from PBMC of B chronic lymphocytic leukemia patients with autoimmune hemolytic anemia produce anti-human red cell antibodies. Leukemia. 11: 687-93. PMID 9180293 DOI: 10.1038/sj.leu.2400645  0.01
1997 Shapira-Nahor O, Marcus H, Segall H, Lubin I, Slavin S, Panet A, Reisner Y. Human T cells recovered from human/Balb radiation chimeras are hypersensitive to human immunodeficiency virus type 1 infection. Journal of Virology. 71: 4495-501. PMID 9151841 DOI: 10.1128/jvi.71.6.4495-4501.1997  0.01
1997 Shimoni A, Marcus H, Canaan A, Ergas D, David M, Berrebi A, Reisner Y. A Model for Human B-Chronic Lymphocytic Leukemia in Human/Mouse Radiation Chimera: Evidence for Tumor-Mediated Suppression of Antibody Production in Low-Stage Disease Blood. 89: 2210-2218. DOI: 10.1182/blood.V89.6.2210  0.01
1996 Marcus H, FActorovich Y, Kulova L, Denes L, Segal H, David M, Burakova T, Reisner Y. Allograft and xenograft rejection in C3H/SCID mice. A new model for the study of non-T cell graft rejection mechanisms. Transplantation. 61: 777-83. PMID 8607183 DOI: 10.1097/00007890-199603150-00018  0.01
1996 Reisner Y, Segall H. Hematopoietic stem cell transplantation for cancer therapy. Current Opinion in Immunology. 7: 687-93. PMID 8573313 DOI: 10.1016/0952-7915(95)80078-6  0.01
1996 Segall H, Lubin I, Marcus H, Canaan A, Reisner Y. Generation of primary antigen-specific human cytotoxic T lymphocytes in human/mouse radiation chimera Blood. 88: 721-730. DOI: 10.1182/blood.V88.2.721.bloodjournal882721  0.01
1995 Levite M, Zinger H, Zisman E, Reisner Y, Mozes E. Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus. Cellular Immunology. 162: 138-45. PMID 7704902 DOI: 10.1006/cimm.1995.1061  0.01
1995 Aboud-Pirak E, Lubin I, Pirak ME, Canaan A, Lowell GH, Reisner Y. Lethally irradiated normal strains of mice radioprotected with SCID bone marrow develop sensitivity to low doses of staphylococcal enterotoxin B. Immunology Letters. 46: 9-14. PMID 7590935 DOI: 10.1016/0165-2478(94)00005-C  0.01
1995 Lubin I, Segall H, Erlich P, David M, Marcus H, Fire G, Burakova T, Kulova L, Reisner Y. Conversion of normal rats into SCID-like animals by means of bone marrow transplantation from SCID donors allows engraftment of human peripheral blood mononuclear cells. Transplantation. 60: 740-7. PMID 7570987 DOI: 10.1097/00007890-199510150-00022  0.01
1995 Kulova L, Denes L, Lubin I, Marcus H, David M, Fire G, Reisner Y. Natural antibodies do not inhibit xenogeneic transplantation of human PBL in lethally irradiated mice Xenotransplantation. 2: 8-18. DOI: 10.1111/j.1399-3089.1995.tb00060.x  0.01
1995 Martelli M, Tabilio A, Falzetti F, Velardi A, Terenzi A, Reisner Y, Aversa F. 11 T-cell depleted haploidentical “three loci” mismatched marrow transplants by addition of T-cell depleted peripheral blood progenitor cells European Journal of Cancer. 31: S3. DOI: 10.1016/0959-8049(95)95263-6  0.01
1994 Lubin I, Segall H, Marcus H, David M, Kulova L, Steinitz M, Erlich P, Gan J, Reisner Y. Engraftment of human peripheral blood lymphocytes in normal strains of mice Blood. 83: 2368-2381. DOI: 10.1182/blood.v83.8.2368.bloodjournal8382368  0.01
1994 Lubin I, Segall H, Marcus H, David M, Kulova L, Steinitz M, Erlich P, Gan J, Reisner Y. Engraftment of human peripheral blood lymphocytes in normal strains of mice Blood. 83: 2368-2381. DOI: 10.1182/blood.v83.8.2368.2368  0.01
1993 Levite M, Reisner Y. Induction of prolonged tolerance to third-party skin grafts following fully allogeneic bone marrow transplantation in mice. Transplantation. 55: 633-8. PMID 8456484 DOI: 10.1097/00007890-199303000-00031  0.01
1992 Lapidot T, Faktorowich Y, Lubin I, Reisner Y. Enhancement of T-cell-depleted bone marrow allografts in the absence of graft-versus-host disease is mediated by CD8+ CD4- and not by CD8- CD4+ thymocytes Blood. 80: 2406-2411. DOI: 10.1182/blood.v80.9.2406.bloodjournal8092406  0.01
1990 Reisner Y. Engraftment of T-cell-depleted bone marrow in murine models for allogeneic bone marrow transplantation. Cancer Treatment and Research. 50: 9-25. PMID 1976360 DOI: 10.1007/978-1-4613-1493-6_2  0.01
1990 Salomon O, Lapidot T, Terenzi A, Lubin I, Rabi I, Reisner Y. Induction of donor-type chimerism in murine recipients of bone marrow allografts by different radiation regimens currently used in treatment of leukemia patients Blood. 76: 1872-1878. DOI: 10.1182/blood.V76.9.1872.bloodjournal7691872  0.01
1989 Lapidot T, Terenzi A, Singer T, Salomon O, Reisner Y. Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts Blood. 73: 2025-2032. DOI: 10.1182/blood.v73.7.2025.2025  0.01
1988 Gale RP, Reisner Y. The role of bone-marrow transplants after nuclear accidents. Lancet (London, England). 1: 923-6. PMID 2895839 DOI: 10.1016/S0140-6736(88)91724-2  0.01
1986 Reisner Y, Ben-Bassat I, Douer D, Kaploon A, Schwartz E, Ramot B. Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation. Proceedings of the National Academy of Sciences of the United States of America. 83: 4012-5. PMID 3520563 DOI: 10.1073/pnas.83.11.4012  0.01
1986 Toporowicz A, Reisner Y. Changes in sialyltransferase activity during murine T cell differentiation. Cellular Immunology. 100: 10-9. PMID 3488816 DOI: 10.1016/0008-8749(86)90002-X  0.01
1986 Gale RP, Reisner Y. Graft rejection and graft-versus-host disease: mirror images. Lancet (London, England). 1: 1468-70. PMID 2873281 DOI: 10.1016/S0140-6736(86)91503-5  0.01
1985 Reisner Y, Sharon N. Fractionation of subpopulations of mouse and human lymphocytes by peanut agglutinin or soybean agglutinin. Methods in Enzymology. 108: 168-79. PMID 6543241 DOI: 10.1016/S0076-6879(84)08084-8  0.01
1984 Friedrich W, Goldmann SF, Vetter U, Fliedner TM, Heymer B, Peter HH, Reisner Y, Kleihauer E. Immunoreconstitution in severe combined immunodeficiency after transplantation of HLA-haploidentical, T-cell-depleted bone marrow. Lancet (London, England). 1: 761-4. PMID 6143084 DOI: 10.1016/S0140-6736(84)91277-7  0.01
1983 Reisner Y. Differential agglutination by soybean agglutinin of human leukemia and neuroblastoma cell lines: potential application to autologous bone marrow transplantation. Proceedings of the National Academy of Sciences of the United States of America. 80: 6657-61. PMID 6356131 DOI: 10.1073/pnas.80.21.6657  0.01
1983 Reisner Y, Kapoor N, Kirkpatrick D, Pollack M, Cunningham-Rundles S, Dupont B, Hodes M, Good R, O'Reilly R. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood. 61: 341-348. DOI: 10.1182/blood.V61.2.341.bloodjournal612341  0.01
1983 Reisner Y, Kapoor N, Kirkpatrick D, Pollack M, Cunningham-Rundles S, Dupont B, Hodes M, Good R, O'Reilly R. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells Blood. 61: 341-348. DOI: 10.1182/blood.v61.2.341.341  0.01
1982 Carroll AM, Reisner Y, de Sousa M. Lyt phenotype and lectin binding properties of mouse lymphocytes which enter lymph nodes. Advances in Experimental Medicine and Biology. 149: 161-5. PMID 6983211 DOI: 10.1007/978-1-4684-9066-4_22  0.01
1982 Barzilay M, Rosenthal E, Kende G, Reisner Y, Sharon N, Ramot B. Binding of peanut agglutinin to normal human lymphocytes and to leukemic cells. Leukemia Research. 6: 123-5. PMID 6951101 DOI: 10.1016/0145-2126(82)90051-0  0.01
1982 Reisner Y, Kapoor N, Hodes M, O'Reilly R, Good R. Enrichment for CFU-C from murine and human bone marrow using soybean agglutinin Blood. 59: 360-363. DOI: 10.1182/blood.v59.2.360.bloodjournal592360  0.01
1982 Reisner Y, Kapoor N, Hodes M, O'Reilly R, Good R. Enrichment for CFU-C from murine and human bone marrow using soybean agglutinin Blood. 59: 360-363. DOI: 10.1182/blood.v59.2.360.360  0.01
1981 Reisner Y, Pahwa S, Chiao JW, Sharon N, Evans RL, Good RA. Separation of antibody helper and antibody suppressor human T cells by using soybean agglutinin. Proceedings of the National Academy of Sciences of the United States of America. 77: 6778-82. PMID 6450419 DOI: 10.1073/pnas.77.11.6778  0.01
1981 Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Dupont B, Good RA, O'Reilly RJ. Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells. Lancet (London, England). 2: 327-31. PMID 6115110 DOI: 10.1016/S0140-6736(81)90647-4  0.01
1981 Reisner Y, Kapoor N, O'Reilly RJ, Good RA. Allogeneic bone marrow transplantation using stem cells fractionated by lectins: VI, in vitro analysis of human and monkey bone marrow cells fractionated by sheep red blood cells and soybean agglutinin. Lancet (London, England). 2: 1320-4. PMID 6109148 DOI: 10.1016/S0140-6736(80)92394-6  0.01
1980 Reisner Y, Ikehara S, Hodes MZ, Good RA. Allogeneic hemopoietic stem cell transplantation using mouse spleen cells fractionated by lectins: in vitro study of cell fractions. Proceedings of the National Academy of Sciences of the United States of America. 77: 1164-8. PMID 6965796 DOI: 10.1073/pnas.77.2.1164  0.01
1980 Ballet JJ, Fellous M, Sharon N, Reisner Y, Agrapart M. Reactivity of human lymphoid and lymphoblastoid cells with peanut agglutinin: detection of a blood cell subset which lacks detectable membrane HLA. Scandinavian Journal of Immunology. 11: 555-60. PMID 6155695 DOI: 10.1111/j.1365-3083.1980.tb00024.x  0.01
1979 Reisner Y, Biniaminov M, Rosenthal E, Sharon N, Ramot B. Interaction of peanut agglutinin with normal human lymphocytes and with leukemic cells. Proceedings of the National Academy of Sciences of the United States of America. 76: 447-51. PMID 311473 DOI: 10.1073/pnas.76.1.447  0.01
1979 Zeicher M, Mozes E, Reisner Y, Lonai P. Selective expression of murine lymphocyte alloantigens controlled by the X-chromosome Immunogenetics. 9: 119-124. DOI: 10.1007/BF01570402  0.01
1978 Umiel T, Linker-Israeli M, Itzchaki M, Trainin N, Reisner Y, Sharon N. Inhibition or acceleration of tumor growth by subpopulations of thymus cells separable by a peanut lectin. Cellular Immunology. 37: 134-41. PMID 306880 DOI: 10.1016/0008-8749(78)90181-8  0.01
1978 Reisner Y, Itzicovitch L, Meshorer A, Sharon N. Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins. Proceedings of the National Academy of Sciences of the United States of America. 75: 2933-6. PMID 26916 DOI: 10.1073/pnas.75.6.2933  0.01
1977 Lahat N, Reisner Y, Sharon N, Moroz C. T-cell neoplasm induced by subcutaneous transplantation of a plasmacytoma: characterization of tumor cells. Cellular Immunology. 34: 180-6. PMID 303154 DOI: 10.1016/0008-8749(77)90240-4  0.01
1976 Reisner Y, Lis H, Sharon N. On the importance of the binding of lectins to cell surface receptors at low lectin concentrations. Experimental Cell Research. 97: 445-8. PMID 942925 DOI: 10.1016/0014-4827(76)90640-6  0.01
Hide low-probability matches.